Mouth Cancer Surgeons
Oral Cancer & Maxillofacial Surgery
Oral Cancer & Maxillofacial Surgery
Oral cancer screening is a quick, painless clinical examination that helps detect early cancer or pre-cancerous changes in the mouth before symptoms develop. It involves visual inspection and gentle palpation of oral tissues and neck lymph nodes. Early detection significantly improves treatment outcomes and survival.
Quick Fact | What You Should Know |
What screening involves | Visual exam + manual palpation of the mouth, tongue, and neck |
Duration | 10–15 minutes; painless and non-invasive |
Who needs it most | Regular tobacco, gutka, or areca nut users; anyone aged 40+ with risk factors |
Recommended frequency | Every 6–12 months for high-risk individuals; annually for moderate-risk |
Screening ≠ diagnosis | Screening identifies what needs closer attention; only a biopsy confirms cancer |
Key clinical red flags | Non-healing ulcer >2 weeks, induration (hardness), fixation to underlying tissue |
Level I evidence | A landmark Kerala trial (Lancet, 2005) showed targeted screening reduced oral cancer mortality by 34% in high-risk groups |
If you have come to this page because something in your mouth is worrying you, or because you use tobacco or betel nut and have been told you should get checked — this is exactly the right place to start.
Screening is not a frightening process. It is a conversation, a careful look, and a clinical judgment about what needs attention and what does not. Most of the time, the answer is reassuring. But on the occasions when something genuinely does need follow-up, catching it at this stage — rather than months later — is what changes the outcome.
Even if nothing serious is found, a screening visit gives you clarity — and that itself reduces a great deal of uncertainty.
I will walk you through everything that happens during a screening visit, who should be screened and how often, what tools are used, and what the findings mean. For detailed information on warning signs and risk factors, please see early signs and symptoms of oral cancer. For treatment and staging, the oral cancer treatment in Chennai — complete guide covers those in full.
Micro-Answer: Screening identifies lesions that may need further assessment. It does not diagnose cancer. Only a biopsy — the examination of tissue under a microscope — can confirm whether something is malignant.
This distinction matters because it shapes how you should interpret a screening visit. If a clinician says they want to monitor something or refer you for further evaluation, that is the screening process working as intended — not a verdict. A concerning finding at screening becomes a reason to investigate, not a reason to panic.
The clinical pathway runs in one direction: Screening → Clinical suspicion → Oral cancer biopsy explained → Diagnosis → Treatment
Each step has its own purpose. This page covers the first and most important one.
A neck dissection is a planned surgery to remove selected lymph nodes from the neck. It may be:
A neck dissection is a planned surgery to remove selected lymph nodes from the neck. It may be:
A neck dissection is a planned surgery to remove selected lymph nodes from the neck. It may be:
A neck dissection is a planned surgery to remove selected lymph nodes from the neck. It may be:
The single most powerful factor in oral cancer outcomes is not which hospital you attend or which surgeon you choose — it is the stage at which the cancer is found.
A cancer identified at Stage I, when it is small and confined to the primary site, carries an approximate five-year survival of 80–90%. The same cancer found at Stage IV carries survival rates of 15–55%, requires far more aggressive treatment, and has a significantly greater impact on function and quality of life.
The challenge is that early oral cancer is often silent. It may be painless. It may look like nothing more than a slightly rough patch or a small ulcer. There is no blood test for it. No scan that screens the general population. The only reliable tool for early detection is a trained clinical eye examining the mouth directly — which is precisely what a screening visit provides.
Micro-Answer: Most early oral cancers cause no pain and produce no obvious symptoms. A clinical screening examination is currently the only reliable method for detecting them before they become symptomatic.
A landmark cluster-randomised controlled trial carried out in Kerala, India, and published in The Lancet (Sankaranarayanan et al., 2005) demonstrated that regular visual screening by trained health workers reduced oral cancer mortality by 34% in high-risk individuals over a 15-year follow-up period. This is Level I evidence — the highest quality available — and it was generated specifically in an Indian population where tobacco and areca nut use are prevalent. The evidence for screening is not theoretical. It is proven.
The most important early warning signs that screening is designed to detect are:
These features are covered in depth on the early signs and symptoms of oral cancer page. The role of this page is to explain what happens when these signs are assessed professionally during a screening examination.
Not everyone carries the same risk. Screening recommendations should be tailored to your individual profile.
You fall into the high-risk category if you:
In Chennai, high-risk patients commonly present with areca nut–related conditions such as OSMF, making regular screening particularly important for this group. For patients with confirmed OSMF or high-risk leukoplakia, six-monthly clinical review is typically a minimum — your specialist may recommend more frequent intervals depending on your specific findings.
Annual screening is appropriate if you:
If you do not have the above risk factors, a visual oral examination by your dentist at every routine dental checkup is appropriate and recommended. This requires no additional appointment — simply asking your dentist to include it takes less than five minutes.
Micro-Answer: High-risk individuals — those who use tobacco, gutka, or betel nut — should undergo clinical oral cancer screening every 6 months. Annual screening is appropriate for former users or those aged 40+ with past exposure.
A monthly self-examination does not replace professional screening, but it can help you notice changes between appointments and know when to seek an earlier review.
If you notice any of these, book a professional evaluation. You do not need to wait for your next scheduled screening.
A professional oral cancer screening is straightforward and takes approximately 10–15 minutes. No injections, no instruments, no discomfort. Here is what to expect.
Before the examination: Your clinician will ask a few questions — your symptoms if any, your tobacco and alcohol history, how long you have had any areas of concern, and relevant medical history. Be honest and specific here; this history guides where attention is focused.
Visual examination: Using a bright light source and a small dental mirror, the clinician systematically examines:
The examination follows a methodical pattern so that no area is skipped.
Manual palpation: The clinician will feel gently inside the mouth — particularly along the tongue, floor of mouth, and cheeks — to detect areas of induration (abnormal hardness or firmness beneath the surface) that may not be apparent on visual inspection alone. Induration at the base of an ulcer is a significant clinical red flag that distinguishes a suspicious lesion from a benign sore.
The neck and jaw area are also examined manually, feeling for:
Fixation to underlying tissue — whether a lesion moves freely or is tethered to deeper structures — is assessed at this stage. A lesion that cannot be moved independently of the underlying tissue suggests deeper invasion and is a significant clinical concern.
Micro-Answer: Three clinical red flags that require urgent further evaluation: a non-healing lesion beyond 2 weeks, induration (abnormal hardness) at the base of a lesion, and fixation to underlying tissue — meaning the lesion cannot be moved freely.
When a suspicious area is identified, or when a patient is in a high-risk category and a thorough assessment is warranted, additional diagnostic tools may be used alongside clinical examination. These are adjunctive — they support clinical judgment, not replace it.
Toluidine blue is a dye that selectively binds to rapidly dividing cells, which are more prevalent in dysplastic and malignant tissue. When applied to a suspicious area, malignant or severely dysplastic tissue typically stains a darker blue than surrounding healthy mucosa.
Its clinical value is in helping identify the most representative area within a large lesion for biopsy — directing the sample to the highest-risk zone rather than taking a random specimen. It also has a role in screening patients with multiple lesions or with OSMF, where the mouth is difficult to assess due to restricted opening.
These devices emit a blue-violet light that causes the oral mucosa to fluoresce. Healthy tissue fluoresces green. Areas with abnormal cell activity — including dysplasia and malignancy — lose this fluorescence and appear darker.
Fluorescence visualisation can help identify lesion extent and may detect changes not visible under white light alone. It is particularly useful for assessing non-homogeneous leukoplakia and for identifying the margins of a lesion before biopsy.
OralCDx is a minimally invasive technique using a stiff-bristled brush to collect cells from the full thickness of the surface epithelium, without requiring local anaesthetic or a surgical incision. The specimen is sent for computer-assisted analysis.
It is not a substitute for a formal surgical biopsy but may be used as an intermediate step for lesions that look clinically low-risk but have been present for longer than expected — providing cytological information to inform the decision about whether a formal biopsy is needed.
For lesions that are being monitored rather than biopsied immediately, standardised clinical photographs provide an objective record for comparison at follow-up visits. Changes in size, colour, or character over time are more reliably tracked with photographic evidence than clinical memory alone.
The following features, when identified during a screening examination, indicate that the lesion requires urgent further evaluation — typically a specialist review and likely biopsy. They are not individually diagnostic of cancer, but each represents a clinical signal that cannot be ignored.
Finding | Clinical Significance |
Non-healing ulcer > 2 weeks | Most consistent early warning sign; benign ulcers resolve in 7–14 days |
Induration at the base | Hardness beneath a lesion suggests deep tissue involvement |
Fixation to underlying tissue | Reduced mobility implies attachment to deeper structures — muscle, bone, or adjacent tissue |
Rolled or raised margins | Suggests active growth at the lesion edge |
Spontaneous or easy bleeding | Abnormal vascularity in the lesion |
Erythroplakia (red patch) | 80–90% show severe dysplasia or carcinoma on first biopsy — biopsy without delay |
New firm lymph node in the neck | May indicate regional spread; requires urgent assessment |
Trismus (restricted mouth opening) | Particularly in areca nut users — associated with OSMF and higher malignant risk |
Numbness of lip, chin, or cheek | May indicate nerve involvement by a deeper process |
If any of these are found during screening, the clinician will advise you on the next step — which is most often a referral for specialist evaluation and consideration of biopsy. The decision about whether a biopsy is needed, and how urgently, is a specialist judgment covered in detail in oral cancer biopsy explained.
What happens after a screening visit depends on what was found.
Nothing of concern identified: You will be advised on your next screening interval based on your risk profile and encouraged to continue monthly self-examination. High-risk patients should return in 6 months regardless of a clear examination.
A lesion found that needs monitoring: Some lesions — particularly small, homogeneous white patches with no suspicious features — may be reviewed at a short follow-up interval (typically 4–6 weeks) rather than immediately biopsied. Photographic documentation is taken. During this interval, any obvious cause such as a sharp tooth or denture edge is eliminated. If the lesion has not resolved at follow-up, further action is taken.
A lesion found that requires specialist evaluation: Any lesion with red flag features — induration, fixation, erythroplakia, size over 1–2cm, location on the floor of mouth or lateral tongue, or duration beyond three weeks — will be referred for specialist assessment. This typically means an appointment with an Oral & Maxillofacial Surgeon or oral oncologist, who will assess whether biopsy is indicated.
A lesion found that requires urgent biopsy: Erythroplakia, any lesion with strong clinical suspicion of malignancy, or findings suggesting advanced pathology will be referred urgently. Biopsy, what it involves, and what the results mean are covered in detail on the oral cancer biopsy explained page.
Micro-Answer: After a screening visit, the outcome is either reassurance with a follow-up plan, watchful monitoring, specialist referral, or urgent biopsy referral. A referral for further assessment does not mean cancer has been found — it means the screening has done its job.
For patients already diagnosed with a pre-malignant oral condition, screening takes on a specific surveillance function. These patients are not simply being checked for new cancers — they are being monitored for changes in existing lesions that may signal progression.
Oral Submucous Fibrosis (OSMF) OSMF is a chronic condition caused primarily by areca nut use, in which the mucosa of the mouth becomes progressively scarred and rigid. It is considered a high-risk pre-malignant condition, particularly in the Indian population. Given the high prevalence of tobacco and betel nut use in Tamil Nadu, OSMF is one of the most frequently encountered pre-malignant conditions seen at oral oncology clinics in Chennai. Malignant transformation rates in OSMF are estimated at 7–13% over the lifetime of the condition. Patients with OSMF should be reviewed every six months at a minimum. Each visit assesses mouth opening (measured in millimetres), the extent and character of mucosal change, and whether any new ulceration or indurated areas have developed.
Leukoplakia under surveillance Not all leukoplakia requires immediate biopsy — but all leukoplakia requires ongoing monitoring. The risk of malignant transformation is highest in non-homogeneous leukoplakia (speckled, erythroleukoplakia, nodular), lesions on the floor of mouth or lateral tongue, lesions in patients who continue tobacco or areca nut use, and lesions that change in appearance over time. Any change — increasing size, new red areas, new induration — warrants a biopsy regardless of when the last one was done.
For detailed information on causes, risk factors, and the full spectrum of pre-malignant conditions, see oral cancer causes and risk factors.
Oral cancer screening in Chennai is available through several pathways:
Dental clinics and hospitals: A trained dentist can and should perform a basic visual oral cancer screening as part of every routine dental visit. If you attend a dental clinic regularly, ask your dentist to include a formal mouth check. They will refer you if anything requires specialist attention.
Oral oncology specialist clinics: For high-risk individuals, or those with known pre-malignant conditions, a dedicated appointment with an Oral & Maxillofacial Surgeon provides a more thorough evaluation including manual palpation, advanced diagnostic aids if indicated, and the ability to proceed to biopsy at the same appointment if needed.
You can schedule a dedicated oral cancer screening consultation with Dr. Pradeep S., Maxillofacial & Oral Cancer Surgeon at Apollo Hospitals, Chennai. The consultation includes a complete clinical examination of the oral cavity and neck, risk assessment, and clear guidance on whether any further tests are needed. You do not need a referral to book an appointment. mouthcancersurgeons.com/book-appointment/
Government cancer screening programmes: Periodic oral cancer screening camps are run by various government and NGO initiatives in Tamil Nadu, particularly in districts with high tobacco and areca nut use. These provide opportunistic screening for populations with limited access to private healthcare.
Micro-Answer: Do not wait for a scheduled screening visit if you have a mouth ulcer that has not healed in two weeks, a new lump in the neck, unexplained restricted mouth opening, or any red patch in the mouth. These require prompt specialist evaluation without delay.
You can contact Dr. Pradeep S. at Apollo Hospitals, Chennai directly. A clinical assessment does not commit you to any treatment — it gives you information.
Dr. Pradeep S., MDS Oral & Maxillofacial Surgeon | Fellow — Head & Neck Oncology Apollo Hospitals, Chennai
Dr. Pradeep S. is an Oral & Maxillofacial Surgeon practising at Apollo Hospitals, Chennai, with a special interest in oral cancer surgery and head & neck oncology. He evaluates and treats patients with cancers of the tongue, buccal mucosa, gingivobuccal complex, and other oral cavity sites, as well as pre-cancerous oral conditions.
His clinical work includes oncologic resection of oral tumours, neck dissection for lymph node involvement, and multidisciplinary management of oral cancer in collaboration with oncology, radiation therapy, and reconstructive surgery teams.
Dr. Pradeep is actively involved in oral cancer awareness, early detection initiatives, and patient education, with a focus on promoting early diagnosis and improving treatment outcomes.
Clinical Focus: Oral cancer diagnosis and surgical management · Tongue cancer and buccal mucosa cancer · Neck dissection for oral cancer · Management of oral potentially malignant disorders · Early detection and screening of oral cancer
Hospital Affiliation: Apollo Hospitals, Chennai
This article was developed with the assistance of advanced AI writing tools to improve clarity and structure. The medical content, clinical explanations, and final review were performed by Dr. Pradeep S., Oral & Maxillofacial Surgeon at Apollo Hospitals, Chennai, to ensure accuracy and reliability. The medical reviewer takes full clinical responsibility for the accuracy of this content.
This article is intended for general patient education and does not constitute medical advice. The information provided is not a substitute for a clinical evaluation by a qualified surgeon or physician. If you have concerns about a mouth ulcer, patch, or any oral symptom, please seek an in-person assessment from an appropriately trained clinician.
Maxillofacial & Oral Cancer Surgeon
No. A standard clinical oral cancer screening involves a visual examination and gentle manual palpation of the mouth and neck. It requires no injections, no instruments, and causes no discomfort. It takes approximately 10–15 minutes.
A trained dentist can and should include a visual oral cancer check as part of every routine dental visit. If a suspicious area is found, or if you are a high-risk individual with known pre-malignant conditions, a specialist evaluation by an Oral & Maxillofacial Surgeon provides a more complete assessment — including manual palpation, neck examination, access to advanced diagnostic tools, and the ability to proceed to biopsy if needed at the same appointment.
Every six months. Tobacco and areca nut users are in the highest-risk category for oral cancer in India. Regular screening every six months is the minimum appropriate interval — and this applies even if you have no symptoms and your previous examinations have been clear.
A clear screening examination means no concerning lesion was identified at that visit. It does not guarantee that a very early lesion will not develop between screenings. This is why regular screening intervals are essential for high-risk individuals, and why monthly self-examination between professional visits is recommended.
These are adjunctive tools that help identify or characterise suspicious areas more accurately. They are not required for every screening visit — a trained clinician using visual and manual examination alone can identify most lesions that need attention. Advanced tools are more commonly used when a suspicious area has already been found and needs further characterisation, or in high-risk patients with multiple lesions where prioritising which area to biopsy is clinically important.
Induration means abnormal firmness or hardness in the tissue — a quality that normal mouth lining does not have. When found at the base of a mouth ulcer or beneath a lesion, it is a significant clinical red flag. It suggests that the change involves deeper tissue layers, not just the surface. It does not confirm cancer, but it does mean a biopsy is typically needed to determine what is causing it.
Yes. The risk of oral cancer does not disappear immediately on quitting tobacco or areca nut — it reduces progressively over years, but former users remain at elevated risk compared to those who have never used these substances. Annual screening is appropriate for former users, particularly if you used tobacco or areca nut heavily or for a long period.
Absolutely — in fact, this is the entire point of screening. The value of a screening examination is detecting pre-malignant changes or early cancers before they cause symptoms. Waiting for symptoms to appear before seeking an examination substantially increases the chance of finding disease at a later, harder-to-treat stage.
If your dentist performed a thorough visual oral examination and found nothing of concern, that is genuinely reassuring. If you are in a high-risk group — using tobacco, areca nut, or alcohol regularly — an annual specialist review adds the value of manual palpation, neck examination, and access to advanced diagnostic tools. It is reasonable to ask your dentist specifically: “Did you examine my tongue, floor of mouth, and neck?” If not all areas were checked, a more complete examination is worthwhile.
Costs vary depending on the type of facility and whether advanced diagnostic aids are used. A basic clinical screening at a dental clinic is generally low cost. A specialist consultation with an Oral & Maxillofacial Surgeon at a hospital includes a comprehensive examination and is more detailed. Your specialist can advise on costs at the time of booking. For patients concerned about cost, community health centres and periodic government screening camps in Tamil Nadu provide free or subsidised screening for high-risk populations.
Not necessarily on the day. If a lesion needs biopsy, this can usually be arranged as an outpatient procedure, and results are typically available within 5–7 working days. Your specialist will discuss the findings with you and advise on the appropriate next steps, which for many patients can be coordinated to minimise travel. Outstation patients should see Traveling to Chennai for Oral Cancer Treatment for practical guidance.
Not currently in routine clinical practice. Salivary biomarker research is an active area of investigation, but no blood test or saliva test has yet been validated for population-level oral cancer screening. The current evidence-based standard remains a clinical visual and manual examination by a trained clinician.